Difference between revisions of "Traebert M, et al, Eur J Pharmacol (2004), cited as Ref 35 in DOI: 10.1007/s11886-020-01293-2 (Q11029)"
Jump to navigation
Jump to search
(Created claim: title (P93): Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells, #quickstatements; #temporary_batch_1592835264664) |
(Created claim: Publication Date (P100): 2004, #quickstatements; #temporary_batch_1592835264664) |
||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2004
| ||||||||||||||
| Property / Publication Date: 2004 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Revision as of 14:16, 22 June 2020
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Traebert M, et al, Eur J Pharmacol (2004), cited as Ref 35 in DOI: 10.1007/s11886-020-01293-2
|
Cited in: "Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34.
|
Statements
Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells (English)
0 references
2004
0 references
